Bank of Nova Scotia purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,191,725 shares of the company's stock, valued at approximately $281,696,000. Bank of Nova Scotia owned approximately 1.70% of Merck KGaA as of its most recent SEC filing.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Frazier Financial Advisors LLC purchased a new position in Merck KGaA during the 2nd quarter valued at about $25,000. Rakuten Securities Inc. bought a new position in shares of Merck KGaA during the second quarter valued at approximately $27,000. Bard Associates Inc. bought a new position in shares of Merck KGaA during the second quarter valued at approximately $60,000. Kilter Group LLC purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $62,000. Finally, Addison Advisors LLC bought a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $90,000. Hedge funds and other institutional investors own 0.10% of the company's stock.
Merck KGaA Stock Performance
Merck KGaA stock opened at $163.21 on Friday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The stock's 50 day moving average is $162.62 and its 200 day moving average is $148.46.
Merck KGaA Profile
(
Free Report)
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company's operations are organized mainly into three businesses.
Read More
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
